Analysts at Cantor Fitzgerald reiterated their "neutral" rating on Rivian (RIVN-0.20%) stock on Sept. 28. Curiously, however, ...

Viking Therapeutics tested various doses of its leading anti-obesity candidate, VK2735, administered subcutaneously every ...

Cal-Maine Foods ( CALM -0.71%) didn't exactly lay an egg with its latest set of quarterly results, but investors didn't find ...

Uber Technologies (UBER-0.97%) has become an unlikely value stock. Analysts anticipate 11% sales growth this year, followed ...

Anthropic is spending heavily on compute; its success will hinge on its revenue growth staying ahead of its expenses.

Since its inception nearly 15 years ago, the Schwab U.S. Dividend Equity ETF has returned 13.2% annually. That's no guarantee ...

The core Personal Consumption Expenditures (PCE) price index rose 0.2% in August, less than economists expected.

The SEC opened a five-year test lane for blockchain stock trading. Most investors can watch this experiment from the ...

Johnson & Johnson ( JNJ -0.54%) seems to be firing on all cylinders. The company's financial results have been strong this ...

At $264 per share, AbbVie still looks reasonably valued at 16 times next year's earnings, and it pays a decent forward yield ...

The other catalyst for the tech stock 's fall today may simply be that investors are taking profits after Corning stock ...

Unlike its hyperscaler peers, Meta Platforms ( META -0.86%) doesn't operate its own legacy cloud computing platform. It's ...